Abstract
The present study does not suggest that somatostatin-14 is handled by the kidney in a manner that is qualitatively different from other small peptides but it appears that the kidney plays only a relatively minor role in the in vivo clearance in comparison to the many other sites of degradation.
| Original language | English |
|---|---|
| Pages (from-to) | 151-152 |
| Number of pages | 2 |
| Journal | HORMONE AND METABOLIC RESEARCH |
| Volume | 16 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published (in print/issue) - 1984 |